Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03165994
Title	APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	University of California, San Francisco
Indications	esophagus adenocarcinoma esophageal carcinoma esophagus squamous cell carcinoma gastroesophageal junction adenocarcinoma
Therapies	Carboplatin + Paclitaxel + Sotigalimab
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 10 of 10 entries

Facility	City	State	Zip	Country	Details
City of Hope Comprehensive Cancer Center	Duarte	California	91010	United States	Details
MedStar Georgetown University Hospital (MGUH)	Washington	District of Columbia	20007-2113	United States	Details
New York University	New York	New York	10016	United States	Details
Renovatio Clinical	The Woodlands	Texas	77380	United States	Details
The University of North Carolina at Chapel Hill	Chapel Hill	North Carolina	27599-7305	United States	Details
University of Arizona	Tucson	Arizona	85719	United States	Details
University of California, San Francisco	San Francisco	California	94143	United States	Details
University of Cincinnati Medical Center	Cincinnati	Ohio	45219	United States	Details
University of Washington	Seattle	Washington	98109	United States	Details
Wake Forest School of Medicine	Winston-Salem	North Carolina	27157	United States	Details

Showing 1 to 10 of 10 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field